Immunotherapy
News and reporting on cancer immunotherapy.
City of Hope, Imugene Begin Trial of Oncolytic Virus in Advanced Solid Cancers
The partners will see if the oncolytic virus CF33-hNIS, dubbed Vaxinia, can increase PD-L1 tumor expression and make patients responsive to Merck's Keytruda.
Odimma Therapeutics, ABL Europe Partner on Personalized Cancer Vaccine Development
ABL will manufacture the viral vector component to deliver personalized cancer neoantigens as part of Odimma's ODI-2001 platform.
OncoHost Raises $35M in Series C Financing
The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.
SCG Cell Therapy to Begin Trials of T-Cell Receptor Therapy for Liver Cancer Patients in Singapore
The firm received IND clearance from regulators in Singapore and China to begin evaluating its therapy SCG101 for HBV-associated hepatocellular carcinoma patients.
MSK to Launch Trial of T-Cell Receptor Therapy Targeting Common Neoantigen With Pharma Partner
Premium
The therapy, which could potentially have tissue-agnostic use, is designed to target a public neoantigen from a mutation in the oncogenic driver gene PIK3CA.